Burleson & Co’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $6.08M | Buy |
37,600
+5,014
| +15% | +$810K | 1.52% | 19 |
|
|
2022
Q3 | $4.37M | Buy |
32,586
+1,594
| +5% | +$214K | 0.94% | 28 |
|
|
2022
Q2 | $4.75M | Sell |
30,992
-196
| -0.6% | -$30K | 1.03% | 28 |
|
|
2022
Q1 | $5.06M | Sell |
31,188
-1,164
| -4% | -$189K | 0.81% | 33 |
|
|
2021
Q4 | $4.38M | Sell |
32,352
-759
| -2% | -$103K | 0.64% | 33 |
|
|
2021
Q3 | $3.57M | Sell |
33,111
-1,249
| -4% | -$135K | 0.53% | 35 |
|
|
2021
Q2 | $3.87M | Buy |
34,360
+218
| +0.6% | +$24.6K | 0.56% | 40 |
|
|
2021
Q1 | $3.7M | Sell |
34,142
-3,566
| -9% | -$386K | 0.6% | 30 |
|
|
2020
Q4 | $4.04M | Sell |
37,708
-154
| -0.4% | -$16.5K | 0.7% | 29 |
|
|
2020
Q3 | $3.52M | Sell |
37,862
-80,695
| -68% | -$7.49M | 0.67% | 33 |
|
|
2020
Q2 | $11M | Buy |
118,557
+21,452
| +22% | +$1.99M | 2.4% | 11 |
|
|
2020
Q1 | $8.15M | Buy |
97,105
+52,988
| +120% | +$4.45M | 2.12% | 11 |
|
|
2019
Q4 | $3.85M | Buy |
44,117
+37
| +0.1% | +$3.23K | 1.08% | 21 |
|
|
2019
Q3 | $3.43M | Buy |
44,080
+3,607
| +9% | +$280K | 1.2% | 22 |
|
|
2019
Q2 | $2.66M | Buy |
40,473
+14,062
| +53% | +$925K | 1.12% | 24 |
|
|
2019
Q1 | $2.08M | Hold |
26,411
| – | – | 0.88% | 31 |
|
|
2018
Q4 | $2.08M | Sell |
26,411
-1,923
| -7% | -$151K | 1.07% | 24 |
|
|
2018
Q3 | $2.54M | Buy |
28,334
+10,467
| +59% | +$936K | 1.42% | 17 |
|
|
2018
Q2 | $1.66M | Buy |
17,867
+1,005
| +6% | +$93.1K | 0.96% | 34 |
|
|
2018
Q1 | $1.6M | Buy |
16,862
+8
| +0% | +$757 | 1.04% | 31 |
|
|
2017
Q4 | $1.63M | Buy |
+16,854
| New | +$1.63M | 1.05% | 25 |
|